AJU IB Investment Co., Ltd. Long-Term Concentrated

CIK: 0001710065 · Show all filings

Period: Q2 2025 (← Previous) (Next →)

Filing Date: Jul 10, 2025

Total Value ($000): $91,890 (100.0% shares, 0.0% debt)

Holdings (8)

ACLX ARCELLX INC 75.1%

Value ($000) $68,982 Shares 1,047,557 Est. Cost $16.72 Unrealized +272.4%

KYMR KYMERA THERAPEUTICS INC 21.7%

Value ($000) $19,946 Shares 457,059 Est. Cost $48.78 Unrealized -29.4%

SEER SEER INC 1.9%

Value ($000) $1,747 Shares 816,375 Est. Cost $63.62 Unrealized -96.9%

XLO XILIO THERAPEUTICS INC 0.5%

Value ($000) $454 Shares 667,742 Est. Cost $17.03 Unrealized -95.6%

CARM CARISMA THERAPEUTICS INC 0.3%

Value ($000) $281 Shares 718,332 Est. Cost $0.82 Unrealized -67.5%

— RALLYBIO CORP 0.3%

Value ($000) $255 Shares 754,678 Est. Cost $9.54 Unrealized —

— SUTRO BIOPHARMA INC 0.1%

Value ($000) $125 Shares 175,000 Est. Cost $21.71 Unrealized —

— RAPT THERAPEUTICS INC 0.1%

Value ($000) $99 Shares 12,437 Est. Cost $19.75 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
ACLX	ARCELLX INC	1,047,557	$68,982	75.1%	$16.72	+272.4%	COMMON STOCK	03940C100
KYMR	KYMERA THERAPEUTICS INC	457,059	$19,946	21.7%	$48.78	-29.4%	COM	501575104
SEER	SEER INC	816,375	$1,747	1.9%	$63.62	-96.9%	COM CL A	81578P106
XLO	XILIO THERAPEUTICS INC	667,742	$454	0.5%	$17.03	-95.6%	COM	98422T100
CARM	CARISMA THERAPEUTICS INC	718,332	$281	0.3%	$0.82	-67.5%	COM	14216R101
—	RALLYBIO CORP	754,678	$255	0.3%	$9.54	—	COM	75120L100
—	SUTRO BIOPHARMA INC	175,000	$125	0.1%	$21.71	—	COM	869367102
—	RAPT THERAPEUTICS INC	12,437	$99	0.1%	$19.75	—	COM NEW	75382E109